Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial

K Inoki1, M Haneda, T Ishida

  • 1The Third Department of Medicine, Shiga University of Medical Science, Seta, Otsu, Japan.

Insights

Transforming growth factor-beta (TGF-beta) activates mitogen-activated protein kinases (MAPKs) in mesangial cells. This pathway is crucial for TGF-beta-induced extracellular matrix production, particularly fibronectin.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta) is a key cytokine regulating cell functions and extracellular matrix (ECM) production.
  • TGF-beta plays a significant role in fibrotic diseases like glomerulosclerosis, but its signaling pathways are not fully understood.
  • Emerging evidence suggests TGF-beta activates signaling cascades including Smad proteins and mitogen-activated protein kinases (MAPKs).

Purpose of the Study:

  • To investigate the role of MAPKs in TGF-beta-induced ECM gene expression in mesangial cells.
  • To determine if MAPK activation mediates TGF-beta's effects on fibronectin production.

Main Methods:

  • Rat mesangial cells were treated with TGF-beta.
  • Mitogen-activated protein kinase (MAPK) activity, specifically extracellular signal-regulated kinase (ERK), was measured.
  • Fibronectin mRNA and protein expression levels were quantified.
  • The effect of PD98059, a MAPK/ERK kinase (MEK) inhibitor, on fibronectin expression was assessed.

Main Results:

  • TGF-beta significantly increased ERK activity in mesangial cells.
  • TGF-beta treatment led to elevated fibronectin mRNA and protein expression.
  • Inhibition of MEK with PD98059 blocked the TGF-beta-induced increase in fibronectin expression.
  • These findings implicate MAPKs in the TGF-beta signaling pathway.

Conclusions:

  • Mitogen-activated protein kinases (MAPKs), specifically the ERK pathway, are essential mediators of TGF-beta-induced extracellular matrix production in mesangial cells.
  • Targeting MAPK signaling may offer therapeutic strategies for fibrotic kidney diseases.
  • This study clarifies a critical signaling cascade in TGF-beta's role in glomerulosclerosis pathogenesis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...